433 related articles for article (PubMed ID: 24727467)
1. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
[TBL] [Abstract][Full Text] [Related]
2. Stiripentol in Dravet syndrome: results of a retrospective U.S. study.
Wirrell EC; Laux L; Franz DN; Sullivan J; Saneto RP; Morse RP; Devinsky O; Chugani H; Hernandez A; Hamiwka L; Mikati MA; Valencia I; Le Guern ME; Chancharme L; de Menezes MS
Epilepsia; 2013 Sep; 54(9):1595-604. PubMed ID: 23848835
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan.
Inoue Y; Ohtsuka Y;
Epilepsy Res; 2015 Jul; 113():90-7. PubMed ID: 25986195
[TBL] [Abstract][Full Text] [Related]
4. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
Elliott J; McCoy B; Clifford T; Wells GA; Coyle D
Pharmacoeconomics; 2018 Oct; 36(10):1253-1261. PubMed ID: 29761351
[TBL] [Abstract][Full Text] [Related]
5. Current therapeutic procedures in Dravet syndrome.
Chiron C
Dev Med Child Neurol; 2011 Apr; 53 Suppl 2():16-8. PubMed ID: 21504427
[TBL] [Abstract][Full Text] [Related]
6. Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study.
De Liso P; Chemaly N; Laschet J; Barnerias C; Hully M; Leunen D; Desguerre I; Chiron C; Dulac O; Nabbout R
Epilepsy Res; 2016 Sep; 125():42-6. PubMed ID: 27389706
[TBL] [Abstract][Full Text] [Related]
7. The European patient with Dravet syndrome: results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome.
Aras LM; Isla J; Mingorance-Le Meur A
Epilepsy Behav; 2015 Mar; 44():104-9. PubMed ID: 25666511
[TBL] [Abstract][Full Text] [Related]
8. Stiripentol: new preparation. Severe myoclonic epilepsy of infancy: promising.
Prescrire Int; 2005 Apr; 14(76):57-9. PubMed ID: 15875342
[TBL] [Abstract][Full Text] [Related]
9. Do children with Dravet syndrome continue to benefit from stiripentol for long through adulthood?
Chiron C; Helias M; Kaminska A; Laroche C; de Toffol B; Dulac O; Nabbout R; An I
Epilepsia; 2018 Sep; 59(9):1705-1717. PubMed ID: 30132836
[TBL] [Abstract][Full Text] [Related]
10. Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome.
Buck ML; Goodkin HP
Ann Pharmacother; 2019 Nov; 53(11):1136-1144. PubMed ID: 31167540
[No Abstract] [Full Text] [Related]
11. Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens: A Randomized Clinical Trial.
Nabbout R; Mistry A; Zuberi S; Villeneuve N; Gil-Nagel A; Sanchez-Carpintero R; Stephani U; Laux L; Wirrell E; Knupp K; Chiron C; Farfel G; Galer BS; Morrison G; Lock M; Agarwal A; Auvin S;
JAMA Neurol; 2020 Mar; 77(3):300-308. PubMed ID: 31790543
[TBL] [Abstract][Full Text] [Related]
12. Stiripentol : in severe myoclonic epilepsy of infancy (dravet syndrome).
Plosker GL
CNS Drugs; 2012 Nov; 26(11):993-1001. PubMed ID: 23018548
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome.
Yıldız EP; Ozkan MU; Uzunhan TA; Bektaş G; Tatlı B; Aydınlı N; Çalışkan M; Özmen M
J Child Neurol; 2019 Jan; 34(1):33-37. PubMed ID: 30362398
[TBL] [Abstract][Full Text] [Related]
15. Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study.
Myers KA; Lightfoot P; Patil SG; Cross JH; Scheffer IE
Dev Med Child Neurol; 2018 Jun; 60(6):574-578. PubMed ID: 29473155
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: additional supportive evidence.
Inoue Y; Ohtsuka Y;
Epilepsy Res; 2014 May; 108(4):725-31. PubMed ID: 24630050
[TBL] [Abstract][Full Text] [Related]
17. Extending the use of stiripentol to other epileptic syndromes: a case of PCDH19-related epilepsy.
Trivisano M; Specchio N; Vigevano F
Eur J Paediatr Neurol; 2015 Mar; 19(2):248-50. PubMed ID: 25510386
[TBL] [Abstract][Full Text] [Related]
18. Stiripentol open study in Japanese patients with Dravet syndrome.
Inoue Y; Ohtsuka Y; Oguni H; Tohyama J; Baba H; Fukushima K; Ohtani H; Takahashi Y; Ikeda S
Epilepsia; 2009 Nov; 50(11):2362-8. PubMed ID: 19552653
[TBL] [Abstract][Full Text] [Related]
19. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
20. Stiripentol for the treatment of seizures in Dravet syndrome.
Eschbach K; Knupp KG
Expert Rev Clin Pharmacol; 2019 May; 12(5):379-388. PubMed ID: 31017478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
